Key result
The O3039 vaccine strain, alone or combined with O1 Manisa, protected cattle against the O/ME-SA/Ind/2001d lineage of FMD virus from clinical disease even at 7 days post-vaccination.
Why the study?
Emerging O/ME-SA/Ind-2001 lineage viruses showed poor in vitro matching and less challenge protection with the widely used O1 Manisa vaccine strain, requiring evaluation of alternative vaccine strains.
The O3039 vaccine strain, alone or with O1 Manisa, provides effective emergency protection in cattle against the emergent O/ME-SA/Ind-2001d FMD virus lineage.
This is the authors' abstract. We don't add key points for this paper.
Vaccination is one of the best approaches to control and eradicate foot-and-mouth disease (FMD). To achieve this goal, vaccines with inactivated FMD virus antigen in suitable adjuvants are being used in addition to other control measures. However, only a limited number of vaccine strains are commercially available, which often have a restricted spectrum of activity against the different FMD virus strains in circulation. As a result, when new strains emerge, it is important to measure the efficacy of the current vaccine strains against these new variants. This is important for countries where FMD is endemic but also for countries that hold an FMD vaccine bank, to ensure they are prepared for emergency vaccination. The emergence and spread of the O/ME-SA/Ind-2001 lineage of viruses posed a serious threat to countries with OIE-endorsed FMD control plans who had not reported FMD for many years. In vitro vaccine-matching results showed a poor match (r1-value < 0.3) with the more widely used vaccine strain O1 Manisa and less protection in a challenge test. This paper describes the use of the O3039 vaccine strain as an alternative, either alone or in combination with the O1 Manisa vaccine strain with virulent challenge by a O/ME-SA/Ind-2001d sub-lineage virus from Algeria (O/ALG/3/2014). The experiment included challenge at 7 days post-vaccination (to study protection and emergency use) and 21 days post-vaccination (as in standard potency studies). The results indicated that the O3039 vaccine strain alone, as well as the combination with O1 Manisa, is effective against this strain of the O/ME-SA/Ind/2001d lineage, offering protection from clinical disease even after 7 days post-vaccination with a reduction in viraemia and virus excretion.
Answers are grounded in this paper and cite their sources.
Updated strain matching remains essential for FMD control; leaves open optimal adjuvant and antigen selection for emerging variants.
No takes yet. Share an insight, caveat, or question.
Singanallur et al. (2021) studied Foot-and-mouth disease (FMD). O3039 vaccine strain alone or combined with O1 Manisa vs. O1 Manisa vaccine strain was evaluated on Protection from clinical disease, reduction in viraemia and virus excretion. The O3039 vaccine strain, alone or combined with O1 Manisa, protected cattle against the O/ME-SA/Ind/2001d lineage of FMD virus from clinical disease even at 7 days post-vaccination.
Synapse has enriched 10 related papers. Consider them for comparative context: